However, individuals who are dialysis-dependent at the start of treatment and have 85-100% glomerular crescents in an adequate biopsy sample do not recover their kidney function and generally will require long-term renal replacement therapy (4). with advanced kidney dysfunction and considerable glomerular crescents is definitely unclear. In particular, the effectiveness of plasmapheresis in dialysis-dependent instances is controversial. We herein statement the successful treatment of a patient with anti-GBM GN who experienced crescents in all glomeruli on a kidney biopsy. The patient was treated with a combination of dialysis, plasmapheresis and immunosuppressive treatment. Aggressive treatments, including the removal of anti-GBM antibodies by plasmapheresis with intense corticosteroid therapy, might be effective in improving the kidney prognosis of anti-GBM GN individuals with no fibrotic lesions. Case Statement A 62-year-old Japanese man was admitted to our hospital having a fever and the progressive development of fatigue. He received an annual medical checkup, and he had never been told that he had kidney dysfunction. One GSK-2881078 year previously, his serum creatinine (s-Cre) had been 0.6 mg/dL, and his urinalysis findings were normal. At the present admission, his blood tests showed severe renal dysfunction [s-Cre 5.97 mg/dL, serum blood urea nitrogen (s-BUN) 50.6 mg/dL] and severe inflammation [serum C-reactive protein (s-CRP) 27.24 mg/dL]. He was positive for serum anti-GBM antibodies (223 EU/mL) and bad for myeloperoxidase anti-neutrophil cytoplasmic antibodies (MPO-ANCAs) and proteinase-3 anti-neutrophil cytoplasmic antibodies (PR3-ANCAs). A urinalysis showed severe hematuria and proteinuria, urinary red blood cell casts and granular casts. His urine volume was 475 mL/day time. He did not possess dyspnea, and his chest simple X-ray film was normal, which indicated that he did not have standard Goodpasture’s disease because of the lack of pulmonary symptoms. Findings on chest computed tomography without contrast agent were normal. KIAA1235 Abdominal computed tomography (no contrast agent) showed GSK-2881078 GSK-2881078 slight enlargement of both kidneys. He was highly suspected of having RPGN, and a kidney biopsy was performed. All 18 glomeruli in the kidney biopsy specimen experienced fibrinoid necrosis, cellular crescents, rupture of the glomerular basement membrane (GBM) and Bowman’s pills, and infiltration of neutrophils. Many neutrophils and monocytes infiltrated round the glomeruli. Plasmacytes and neutrophils experienced infiltrated almost 100% of the regions of the kidney cortex interstitium with tubulitis; however, there were no GSK-2881078 apparent fibrotic changes in the cortex interstitium. Immunofluorescent staining showed that IgG antibodies were deposited inside a linear pattern along the GBM. The pathological analysis was diffuse necrotizing crescentic glomerulonephritis, which is compatible with anti-GBM GN (observe Fig. 1). Open in a separate window Number 1. Histology of the kidney biopsy specimens. (a) Periodic acid-Schiff staining, unique magnification 100. (b) Periodic acid methenamine metallic staining, unique magnification 400. All 18 glomeruli in the kidney biopsy specimen experienced cellular crescents, and almost 100% of the regions of the kidney cortex interstitium experienced tubulitis. There were no fibrocellular or fibrotic crescents and no apparent fibrotic changes in the cortex interstitium. (c) Direct immunofluorescent IgG antibody staining, unique magnification 200. IgG antibodies were deposited inside a linear pattern along the glomerular basement membrane. Plasmapheresis to remove anti-GBM antibodies from his serum was started immediately. GSK-2881078 Plasmapheresis was performed on three consecutive days, and then every other day time, four instances, for a total of seven instances. In each plasmapheresis session, the treated volume was 1.2 plasma volume, and the replacement fluid consisted of 1,000 mL of 5% albumin plus 2,700 mL of fresh-frozen plasma (FFP). We replaced his eliminated plasma 1st with albumin and then with FFP. In addition to plasmapheresis, he was treated with rigorous corticosteroids therapy, including methylprednisolone (mPSL) pulse therapy (1 g/day time continually for 3 days) and oral prednisolone, 40 mg/day time, to inhibit the production of anti-GBM antibodies and reduce kidney swelling. Oliguria worsened, and the s-Cre increased to 9.17 mg/dL. Consequently, he was started on hemodialysis therapy three times per week, simultaneously. Due to these therapies, including the seven plasmapheresis therapy classes, his fever improved, and the levels of swelling markers decreased. His urine volume improved, and his renal function gradually improved. After undergoing hemodialysis for 41 days, he finally discontinued it. However, the levels of anti-GBM antibodies improved, and his kidney function worsened again. Consequently, we performed two more classes of plasmapheresis therapy. Each plasmapheresis session consisted of 0.93 plasma volume, with.